Literature DB >> 26407358

Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics.

Adam L Hersh1, Jeffrey S Gerber2, Lauri A Hicks3, Andrew T Pavia1.   

Abstract

The use of fluoroquinolones differs dramatically between adult and pediatric patients. For adults, they are the leading class of antibiotics prescribed in ambulatory care visits whereas in children, they are the least frequently prescribed class. The reasons for this difference in practice likely relate to perceptions of their potential for harm. This highlights the impact of physicians' perception of direct patient harm in antibiotic decision making which has implications for antibiotic stewardship.
© The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibacterial agents; drug resistance; physician's practice patterns.

Mesh：

Substances：

Year:  2014        PMID： 26407358      PMCID： PMC5965879          DOI： 10.1093/jpids/piu044

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  14 in total

1.  The use of systemic and topical fluoroquinolones.

Authors:  John S Bradley; Mary Anne Jackson
Journal:  Pediatrics       Date:  2011-09-26       Impact factor: 7.124

2.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients.

Authors:  Joshua P Metlay; Judy A Shea; Linda B Crossette; David A Asch
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

4.  Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09.

Authors:  Daniel J Shapiro; Lauri A Hicks; Andrew T Pavia; Adam L Hersh
Journal:  J Antimicrob Chemother       Date:  2013-07-25       Impact factor: 5.790

5.  Trends in adverse reactions to trimethoprim-sulfamethoxazole.

Authors:  Jennifer L Goldman; Mary Anne Jackson; Joshua C Herigon; Adam L Hersh; Daniel J Shapiro; J Steven Leeder
Journal:  Pediatrics       Date:  2012-12-03       Impact factor: 7.124

6.  Antibiotic exposure and IBD development among children: a population-based cohort study.

Authors:  Matthew P Kronman; Theoklis E Zaoutis; Kevin Haynes; Rui Feng; Susan E Coffin
Journal:  Pediatrics       Date:  2012-09-24       Impact factor: 7.124

7.  Clostridium difficile infection among children across diverse US geographic locations.

Authors:  Joyanna M Wendt; Jessica A Cohen; Yi Mu; Ghinwa K Dumyati; John R Dunn; Stacy M Holzbauer; Lisa G Winston; Helen L Johnston; James I Meek; Monica M Farley; Lucy E Wilson; Erin C Phipps; Zintars G Beldavs; Dale N Gerding; L Clifford McDonald; Carolyn V Gould; Fernanda C Lessa
Journal:  Pediatrics       Date:  2014-03-03       Impact factor: 7.124

8.  Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial.

Authors:  Jeffrey S Gerber; Priya A Prasad; Alexander G Fiks; A Russell Localio; Robert W Grundmeier; Louis M Bell; Richard C Wasserman; Ron Keren; Theoklis E Zaoutis
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

9.  Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics.

Authors:  Adam L Hersh; Mary Anne Jackson; Lauri A Hicks
Journal:  Pediatrics       Date:  2013-11-18       Impact factor: 7.124

10.  Prescribing "placebo treatments": results of national survey of US internists and rheumatologists.

Authors:  Jon C Tilburt; Ezekiel J Emanuel; Ted J Kaptchuk; Farr A Curlin; Franklin G Miller
Journal:  BMJ       Date:  2008-10-23
View more
  6 in total

Review 1.  Safety Concerns Surrounding Quinolone Use in Children.

Authors:  Karisma Patel; Jennifer L Goldman
Journal:  J Clin Pharmacol       Date:  2016-03-28       Impact factor: 3.126

2.  Fluoroquinolone Antibiotics and Tendon Injury in Adolescents.

Authors:  Rachael K Ross; Alan C Kinlaw; Mackenzie M Herzog; Michele Jonsson Funk; Jeffrey S Gerber
Journal:  Pediatrics       Date:  2021-05-14       Impact factor: 9.703

Review 3.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

4.  Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes.

Authors:  Sarah C J Jorgensen; Samantha L Yeung; Mira Zurayk; Jill Terry; Maureen Dunn; Paul Nieberg; Jean Pallares; Annie Wong-Beringer
Journal:  Open Forum Infect Dis       Date:  2018-05-02       Impact factor: 3.835

5.  Real-world safety evaluation of musculoskeletal adverse events associated with Korean pediatric fluoroquinolone use: a nationwide longitudinal retrospective cohort study.

Authors:  Yoonhye Kim; Minwoo Paik; Chanjoo Khan; Yae-Jean Kim; EunYoung Kim
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

Review 6.  Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review.

Authors:  Jef Willems; Eline Hermans; Petra Schelstraete; Pieter Depuydt; Pieter De Cock
Journal:  Paediatr Drugs       Date:  2020-11-10       Impact factor: 3.022
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.